Physician profile
Nicholas Roy
NPI 1619288073
$7,084.58
in general payments reported to CMS, 2019-2025
38 companies · $1,930 in 2025
The $1,930 reported for 2025 was more than what 86% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $383 · 2021: $665 · 2022: $1,034 · 2023: $983 · 2024: $1,390 · 2025: $1,930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,145 · Education: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,144.83 |
| Education | $157.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,541.27 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,395.69 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Regeneron Healthcare Solutions, INC. | $640.01 | 2019-2025 | Dupixent |
| Genzyme Corporation | $620.47 | 2019-2025 | |
| Amgen INC. | $331.76 | 2022-2025 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $313.71 | 2019-2025 | Stiolto Respimat, Spiriva Respimat, Ofev |
| Sanofi-Aventis U.S. LLC | $234.97 | 2022-2025 | |
| Insmed, INC. | $234.76 | 2022-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $216.31 | 2019-2024 | Yupelri |
| Philips North America LLC | $204.79 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Grifols USA, LLC | $133.02 | 2022-2025 | Prolastin-C Liquid |
| Genentech USA, INC. | $131.15 | 2019-2024 | Xolair |
| Electromed, INC. | $130.48 | 2019-2025 | Smartvest |
| Actelion Pharmaceuticals US, INC. | $117.47 | 2019-2025 | Uptravi, Opsumit |
| Takeda Pharmaceuticals U.S.A., INC. | $115.35 | 2023-2025 | Aralast |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $107.05 | 2025 | Ohtuvayre |
| Baxter Healthcare | $83.67 | 2023-2025 | Hillrom - Life 2000 Ventilation System |
| Novartis Pharmaceuticals Corporation | $69.68 | 2019-2023 | |
| United Therapeutics Corporation | $46.66 | 2021-2025 | Tyvaso, Tyvaso |
| Jazz Pharmaceuticals INC. | $45.48 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $39.45 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $39.43 | 2025 | Purified Cortrophin Gel |
| Azurity Pharmaceuticals, INC. | $34.59 | 2024-2025 | Alvesco, Horizant |
| Resmed Corp | $34.36 | 2019-2024 | |
| Advanced Respiratory, INC | $26.39 | 2020 | |
| Phadia US INC. | $18.70 | 2025 | Immunocap |
| Harmony Biosciences LLC | $18.23 | 2025 | |
| Inogen, INC. | $16.76 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Axsome Therapeutics, INC. | $16.41 | 2024 | Sunosi |
| Pulmonx Corporation | $16.20 | 2022 | |
| Viatris Specialty LLC | $16.04 | 2025 | Yupelri |
| Lilly USA, LLC | $14.99 | 2025 | Zepbound |
| Pharming Healthcare, INC. | $14.96 | 2023 | Ruconest |
| Idorsia Pharmaceuticals US INC | $13.68 | 2022 | |
| Sunovion Pharmaceuticals INC. | $13.32 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.02 | 2019 | |
| Circassia INC. | $12.46 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.